Cargando…
Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia–reperfusion injury
Hydrogen sulfide (H(2)S) functions as a protective gas transmitter in various physiological and pathological processes, but the lack of ideal donors severely hampers the clinical application of H(2)S. This study aims to construct a controlled release H(2)S donor and evaluate its protective effect on...
Autores principales: | Wang, Wenshuo, Sun, Xiaotian, Zhang, Huili, Yang, Cheng, Liu, Ye, Yang, Wuli, Guo, Changfa, Wang, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957682/ https://www.ncbi.nlm.nih.gov/pubmed/27486324 http://dx.doi.org/10.2147/IJN.S104604 |
Ejemplares similares
-
A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury
por: Sun, Xiaotian, et al.
Publicado: (2017) -
Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury
por: Wu, Dongdong, et al.
Publicado: (2015) -
Controlled-releasing hydrogen sulfide donor based on dual-modal iron oxide nanoparticles protects myocardial tissue from ischemia–reperfusion injury
por: Wang, Wenshuo, et al.
Publicado: (2019) -
The Role of the Signaling Pathways Involved in the Protective Effect of Exogenous Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury
por: Lv, Shuangyu, et al.
Publicado: (2021) -
Hydrogen Sulfide and Endothelium-Dependent Vasorelaxation
por: Bełtowski, Jerzy, et al.
Publicado: (2014)